These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2567491

  • 1. HLA antigens in drug-induced parkinsonism.
    Metzer WS, Newton JE, Steele RW, Claybrook M, Paige SR, McMillan DE, Hays S.
    Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491
    [Abstract] [Full Text] [Related]

  • 2. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R, Kay SR.
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [Abstract] [Full Text] [Related]

  • 3. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S, Debsikdar V.
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [Abstract] [Full Text] [Related]

  • 4. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L, Caligiuri MP, Williams R, Schieldrop P, Manchanda R, Malla A, Harricharan R.
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [Abstract] [Full Text] [Related]

  • 5. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC, Atbaşoğlu EC, Balaban H.
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 7. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H, Geraisy N, Schwartz M.
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [Abstract] [Full Text] [Related]

  • 8. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E.
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [Abstract] [Full Text] [Related]

  • 9. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

  • 10. Vulnerability to tardive dyskinesia.
    Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD.
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [Abstract] [Full Text] [Related]

  • 11. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
    Chouinard G, Annable L, Ross-Chouinard A, Kropsky ML.
    J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
    [Abstract] [Full Text] [Related]

  • 12. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
    Kang SG, Choi JE, An H, Lim SW, Lee HJ, Han C, Kim YK, Kim SH, Cho SN, Lee MS, Joe SH, Jung IK, Kim L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1545-8. PubMed ID: 18602732
    [Abstract] [Full Text] [Related]

  • 13. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS, Paige SR, Newton JE.
    Mov Disord; 1993 Aug 01; 8(1):43-6. PubMed ID: 8093548
    [Abstract] [Full Text] [Related]

  • 14. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, Wang JJ, Lu XQ.
    Acta Pharmacol Sin; 2006 Mar 01; 27(3):328-32. PubMed ID: 16490169
    [Abstract] [Full Text] [Related]

  • 15. Seborrheic dermatitis in neuroleptic-induced parkinsonism.
    Binder RL, Jonelis FJ.
    Arch Dermatol; 1983 Jun 01; 119(6):473-5. PubMed ID: 6134496
    [Abstract] [Full Text] [Related]

  • 16. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL, Bagli M, Krauss H, Müller DJ, Schulze TG, Fangerau H, Ludwig M, Barkow K, Held T, Heun R, Maier W, Rietschel M, Rao ML.
    Pharmacopsychiatry; 2003 Jun 01; 36(2):73-8. PubMed ID: 12734765
    [Abstract] [Full Text] [Related]

  • 17. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE, Povlsen UJ, Meidahl B, Gerlach J.
    Psychopharmacol Bull; 1986 Jun 01; 22(1):250-3. PubMed ID: 2873612
    [No Abstract] [Full Text] [Related]

  • 18. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME, Chevesich J, Lehrer E, Mosnaim AD.
    Biol Psychiatry; 1983 Oct 01; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptics and nicotine].
    Erdmann R.
    Psychiatr Prax; 1995 Nov 01; 22(6):223-7. PubMed ID: 8570751
    [Abstract] [Full Text] [Related]

  • 20. [Parkinsonism during lithium use].
    Walrave TR, Bulens C.
    Tijdschr Psychiatr; 2009 Nov 01; 51(2):123-7. PubMed ID: 19194854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.